Recent Analyst Stock Rating News
Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)
Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
3 Keros Analysts On Why Biopharma Is A Compelling Investment Opportunity
Jefferies Downgrades La Jolla On Weak Forecast For Blood Pressure Drug
Analysts See Potential In The NuCana Pipeline
Array BioPharma And Others Shine At The ESMO 2017 Congress
Amgen Follows Up Positive Clinical News With Earnings Beat; Jefferies Sees 24% Upside
Why Spinraza Is The Only Exciting Thing About Ionis Pharmaceuticals
Array BioPharma Marches Higher On Phase 3 Columbus Success
Jefferies Downgrades Tesaro Following 108% Stock Move
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.